The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of a multidisciplinary program for evaluation and treatment of pancreatic cancer in a community healthcare system.
 
Robert C. Hermann
Research Funding - Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); CytRx Corporation (Inst); EMD Serono (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst)
 
Scott Early
No Relationships to Disclose
 
Sachin Goel
No Relationships to Disclose
 
Justin Hart
No Relationships to Disclose
 
Magali Huertas
Stock and Other Ownership Interests - Biogen; Bristol-Myers Squibb; Cardinal Health; Celgene; GlaxoSmithKline; GW Pharmaceuticals; Juno Therapeutics; Novartis; Regeneron
Honoraria - Bayer
 
Chad Khulman
Travel, Accommodations, Expenses - Sirtex Medical
 
Leigh Webb
Consulting or Advisory Role - Registry Partners
 
Barbara J Wilson
Honoraria - Amgen
Speakers' Bureau - Amgen
 
Sahir Shroff
No Relationships to Disclose